Monaco Biennial Cancer Congress to spotlight advances in oncology, the use of AI and therapeutic treatments

Cancer is the leading noncommunicable cause of death in France and accounted for over 185,000 deaths in the country in 2022. With almost 500,000 new cases reported each year and an incidence rate that has doubled since 1990, finding effective new ways of treating and preventing cancer has never been more of a priority.  

That mission is the primary focus of a meeting of more than 1,500 oncologists and healthcare professionals from the Francophone world, who are set to meet in Monaco later this month: the Monaco Biennial Cancer Congress, which is now in its 16th edition, will be held at the Grimaldi Forum from 23rd to 26th January.  

These specialists will be convening to “present and evaluate all the major advances in oncology, pharmacy and haematology, in patient care, diagnostics, therapeutic treatments, screening technologies and care available”.  

“News in cancerology has continued to develop both in terms of research, patient care and the evolution of treatments over the last two years,” says Professor Xavier Pivot, the president of the event. “The Monaco Biennial Cancer Congress allows us to take stock of the state of our progress in all disciplines and to disseminate as widely as possible knowledge on the means of combating and future developments against cancer.”  

Under the aegis of the Centre Scientifique de Monaco and the CHPG

In all, there will be some 90 different scientific sessions to choose from, including some new additions and particularly special events.  

“A new feature for this edition is the establishment on 24th January of 12 academic sessions with communications of original work selected by a jury of experts,” explains Professor Pivot. “This approach will place the [event] as an important academic milestone, allowing the promotion of players in French oncology, strengthening the dissemination of knowledge. This edition will give us the opportunity to provide a comprehensive update on the state of knowledge.” 

The conference will also look at how the use of artificial intelligence (AI) in the diagnosis of pathologies and the treatment of patients is coming to the forefront. Several sessions will be devoted to this topic.  

The event is being organised by Publi Création-Lena Group with the support of AFISM under the High Patronage of Prince Albert II of Monaco and under the aegis of the Centre Scientifique de Monaco and the Centre Hospitalier Princesse Grace.

Click here for more information about the congress.


Join the Monaco Life community – the largest English media in the Principality.   

Sign up for the Monaco Life newsletter, and follow us on Facebook, Instagram, LinkedIn and Tik Tok. 


Photo via Grimaldi Forum, Facebook